Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) is a stock to buy at UBS and a potential acquisition ... They included Idenix Pharmaceuticals Inc. (NASDAQ: IDIX), Insmed Inc. (NASDAQ: INSM), InterMune Inc. (NASDAQ: ITMN), Puma …
Here are the top stories from the stock market today: 1. Deals, deals, deals in pharma and meats: Merck announced earlier this morning that it was going to acquire Idenix Pharmaceuticals (IDIX), a hepatitis C drug producer for $24.50 a …
The GuruFocus 52-week low screener also shows that Idenix Pharmaceuticals Inc. ( IDIX) is at a 52-week low of $3.53 (high ... This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the …
The stock has gained 1.4% over the last year. 10. Idenix Pharmaceuticals Inc. (IDIX): Biotechnology Industry. Market cap of $581.71M. Beta at 0.23. Net insider shares purchased over the last six months at 38.08K, which is 0.06% of the …
The stock price of Idenix Pharmaceuticals Inc (NYSE:IDIX) surged more than 12% to $5.81 per share due to the promising data from the clinical trial of IDX21437. However, Brian P. Skorney, an analyst at Baird Equity Research, expressed …
Idenix Pharmaceuticals (IDIX): Shares are upgraded to Outperform from Market Perform ... Meritor (MTOR): Morgan Stanley moves the small cap stock up by an unusual 180 degrees, to Overweight from Underweight. Daimler AG (DDAIF): …
Idenix Pharmaceuticals (NASDAQ: IDIX) and Spectrum Pharmaceuticals (NASDAQ ... The company also recently announced a stock offering. Idenix is headquartered in Cambridge, Mass., and develops drugs for the treatment of …
Idenix /quotes/zigman/90571/delayed /quotes/nls/idix IDIX is a biopharmaceutical company that specializes ... for Gilead’s /quotes/zigman/72849/delayed /quotes/nls/gild GILD stock given the greater credibility and resources that Merck brings …
Amicus Therapeutics Inc. (NASDAQ ... Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) shares declined 4.57 percent to …
The company is being purchased by Mallinckrodt (NYSE:MNK) for $5.2 billion in cash and stock. Questcor and Mallinckrodt are part of John Paulson’s portfolio. Second comes Idenix Pharmaceuticals Inc (NASDAQ:IDIX), up …